Concepedia

Jeffrey Skinner

JS

Statistics

Publications

7

Citations

347

H-Index

7

Active since

2018

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Jeffrey Skinner is an author at The University of Texas MD Anderson Cancer Center specializing in pharmacotherapy, health sciences, and hematology.

Top concepts

Publications per year

2018–2024

7

Publications

7

Long‐term follow‐up of lower dose dasatinib (50 mg daily) as frontline therapy in newly diagnosed chronic‐phase chronic myeloid leukemia

Kiran Naqvi, Elias Jabbour, Jeffrey Skinner et al. · Cancer · 2019 · 123 citations · Full text

Early results of lower dose dasatinib (50 mg daily) as frontline therapy for newly diagnosed chronic‐phase chronic myeloid leukemia

Kiran Naqvi, Elias Jabbour, Jeffrey Skinner et al. · Cancer · 2018 · 69 citations · Full text

Low‐dose dasatinib 50 mg/day versus standard‐dose dasatinib 100 mg/day as frontline therapy in chronic myeloid leukemia in chronic phase: A propensity score analysis

Elias Jabbour, Koji Sasaki, Fadi Haddad et al. · American Journal of Hematology · 2022 · 48 citations · Full text

, , +12

The LEukemia Artificial Intelligence Program (LEAP) in chronic myeloid leukemia in chronic phase: A model to improve patient outcomes

Koji Sasaki, Elias Jabbour, Farhad Ravandi et al. · American Journal of Hematology · 2020 · 34 citations · Full text

Long‐term results of frontline dasatinib in chronic myeloid leukemia

Abhishek Maiti, Jörge E. Cortes, Keyur P. Patel et al. · Cancer · 2020 · 33 citations

1–5 of 7